Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
99.59%
Operating Margin
28.24%
Net Margin
24.55%
Efficiency Metrics
Revenue per Expense Ratio
3.53
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
72.12%
Income Tax Rate
0.00%
EPS
0.2700000000
Balance Sheet Analysis
Current Ratio
26.12
Cash Ratio
26.12
Working Capital
$12.12M
Debt to Equity
1.09
Debt to Assets
40.24%
Equity Ratio
36.78%
Cash Flow Analysis
Operating Cash Flow Ratio
33.74%
Free Cash Flow Ratio
33.39%
CapEx to Revenue
0.35%
Dividends Paid
$25.73M
Stock Buybacks
$226.33K
Total Shareholder Returns
$25.95M
Cash Position Change
-46.87%
Detailed Growth Metrics
Core Performance
Revenue
17.26%
Net Income
-23.96%
EPS
-40.83%
Operating Income
-57.78%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
279.30%
Operating Cash Flow
153.21%
Free Cash Flow
212.35%
Balance Sheet Health
Assets
1,256.29%
Debt
52,668.83%
Book Value per Share
325.90%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
-2.45%
Shares Outstanding
17.23%
Long Term Trends
3Y Revenue/Share
74.06%
5Y Revenue/Share
94.04%
3Y Dividend/Share
61.51%
5Y Dividend/Share
32.15%